Spinal radiographic progression over 2years in ankylosing spondylitis patients treated with secukinumab: a historical cohort comparison

J. Braun*, H. Haibel, M. de Hooge, R. Landewe, M. Rudwaleit, T. Fox, A. Readie, H. B. Richards, B. Porter, R. Martin, D. Poddubnyy, J. Sieper, D. van der Heijde

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number142
Number of pages8
JournalArthritis Research & Therapy
Volume21
DOIs
Publication statusPublished - 7 Jun 2019

Keywords

  • Ankylosing spondylitis
  • Radiographic progression
  • Interleukin-17A
  • Secukinumab
  • Retrospective cohort study
  • Biologic therapy
  • Nonsteroidal anti-inflammatory drugs
  • NONSTEROIDAL ANTIINFLAMMATORY DRUGS
  • OUTCOMES

Cite this

Braun, J., Haibel, H., de Hooge, M., Landewe, R., Rudwaleit, M., Fox, T., Readie, A., Richards, H. B., Porter, B., Martin, R., Poddubnyy, D., Sieper, J., & van der Heijde, D. (2019). Spinal radiographic progression over 2years in ankylosing spondylitis patients treated with secukinumab: a historical cohort comparison. Arthritis Research & Therapy, 21, [142]. https://doi.org/10.1186/s13075-019-1911-1